Turning Point Therapeutics 9.25M share IPO priced at $18.00
The deal size was increased from 8.82M shares and priced at the top of the $16.00-$18.00 range. Goldman Sachs is acting as lead book running manager for the offering. https://thefly.com/landingPageNews.php?id=2893545
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.